- Title
- Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6
- Creators
- Mika KURKELA - Drug Discovery and Development Technology Center (DDTC) and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, FinlandAnne-Sisko PATANA - Institute of Biotechnology, University of Helsinki, Helsinki, FinlandPeter I MACKENZIE - Department of Clinical Pharmacology, Flinders University and Flinders Medical Centre, Bedford Park, AustraliaMichael H COURT - Molecular Pharmacogenetics Laboratory, Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, United StatesChristopher G TATE - MRC Laboratory of Molecular Biology, Cambridge, United KingdomJouni HIRVONEN - Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FinlandAdrian GOLDMAN - Institute of Biotechnology, University of Helsinki, Helsinki, FinlandMoshe FINEL - Drug Discovery and Development Technology Center (DDTC) and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
- Publication Details
- Pharmacogenetics and genomics, Vol.17(2), pp.115-126
- Academic Unit
- Veterinary Clinical Sciences, Department of
- Publisher
- Lippincott Williams and Wilkins; Hagerstown, MD
- Identifiers
- 99900547373601842
- Language
- English
- Resource Type
- Journal article
Journal article
Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6
Pharmacogenetics and genomics, Vol.17(2), pp.115-126
2007
Handle:
https://hdl.handle.net/2376/109341
PMID: 17301691
Abstract
Metrics
13 Record Views